Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T-cryptantigen determination affects mortality in necrotizing enterocolitis

R W Novak1, A E Abbott, R L Klein

  • 1Department of Pathology, Children's Hospital Medical Center, Akron, Ohio.

Surgery, Gynecology & Obstetrics
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis.

Gene therapy·2014
Same author

AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson's disease.

Gene therapy·2009
Same author

Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.

Diabetic medicine : a journal of the British Diabetic Association·2006
Same author

Lipoproteins and diabetic microvascular complications.

Current pharmaceutical design·2004
Same author

Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats.

Neuroscience·2002
Same author

Burn wound itch control using H1 and H2 antagonists.

The Journal of burn care & rehabilitation·2001

Screening infants for Thomsen-Friedenreich cryptantigen (TCA) exposure before blood transfusions significantly reduces hemolytic reactions and mortality in necrotizing enterocolitis cases. This proactive approach improves patient outcomes and management.

Area of Science:

  • Neonatal Medicine
  • Hematology
  • Immunology

Background:

  • Infants with necrotizing enterocolitis (NEC) may be exposed to the Thomsen-Friedenreich cryptantigen (TCA).
  • TCA exposure can lead to severe hemolytic reactions during transfusions with plasma-containing blood products.
  • Screening for TCA exposure in NEC patients is advocated for transfusion safety.

Purpose of the Study:

  • To evaluate the impact of screening for Thomsen-Friedenreich cryptantigen (TCA) exposure on patient management and outcomes in infants with necrotizing enterocolitis.
  • To compare the incidence of hemolysis and mortality rates between NEC patients managed with and without knowledge of TCA exposure status.

Main Methods:

  • A retrospective comparison of 62 infants managed with knowledge of TCA exposure status versus 66 infants not screened during comparable four-year periods.

Related Experiment Videos

  • Assessment of hemolytic reactions and mortality rates following blood transfusions in both groups.

    • Main Results:

    • The unscreened group showed a significantly higher incidence of hemolysis post-transfusion (42% vs. 15%, p < 0.05).
    • Mortality was significantly greater in the unscreened group (18.0% vs. 4.5%, p < 0.05).
    • Knowledge of TCA exposure status during management was associated with improved outcomes.

    Conclusions:

    • Screening for Thomsen-Friedenreich cryptantigen (TCA) exposure is crucial for managing infants with necrotizing enterocolitis.
    • TCA screening aids in diagnosis, prognosis, and importantly, in patient management, leading to reduced hemolysis and mortality.
    • Implementing TCA screening protocols can significantly improve outcomes for high-risk neonatal patients.